SCHEMBL3582069

SCHEMBL3582069

Cc1[nH]c2c(OCc3cccnc3)ccnc2c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.46
MAOA P21397 1/20 0.46
DYRK1A Q13627 1/20 0.46
HTR1A P08908 2/20 0.44
DRD2 P14416 2/20 0.44
BRD4 O60885 1/20 0.43
GCK P35557 1/20 0.41
PRKDC P78527 2/20 0.40
IKBKB O14920 1/20 0.39
SLC6A4 P31645 1/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
ALDH1A1 P00352 1/20 0.38
POLB P06746 1/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3597264 0.82 HTR6 (0.44) HTR6MAOAHTR1AMAPTMEN1
SCHEMBL3592904 0.79 HTR6 (0.42) HTR6SLC6A4ALDH1A1POLBKDM4E
SCHEMBL3588534 0.79 MEN1 (0.44) MAOAALDH1A1KDM4EMAPTMEN1
SCHEMBL3591662 0.79 KMT2A (0.48) HTR1ABRD4SLC6A4ALDH1A1POLB
SCHEMBL3591925 0.78 ACHE (0.36) HTR6BRD4ALDH1A1POLBKDM4E
SCHEMBL3579422 0.77 IDO1 (0.39) MAOAPOLBKDM4EMAPTMEN1
SCHEMBL3589577 0.76 SYK (0.46) MAOAHTR1ADRD2BRD4GCK
SCHEMBL3576383 0.76 MPO (0.40) SLC6A4
SCHEMBL3583639 0.73 MAPT (0.38) HTR1ABRD4ALDH1A1KDM4EMAPT
SCHEMBL3593008 0.72 L3MBTL1 (0.46) ALDH1A1POLBKDM4EMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784403-B1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2013-07-17 EP disclosed
US-7642269-B2 Pyrrolo[3,2-B]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-01-05 US disclosed
US-20070213358-A1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-13 US disclosed
EP-1784403-A1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Yuhan Corporation (KR) 2007-05-16 EP disclosed
WO-2006038773-A1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2006-04-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070213358-A1 PYRROLO[3,2-B]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, PPOX HTR6 1289/4885MAOA 1709/4885DYRK1A 596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.